Bioelectronics Corp (BIEL)

[dcsteve]

Approval on the way- what changed since 2010 denial-

1) Regulatory support from the law firm of Goodwin Proctor

2) Three clinical trials on ActiPatch use in osteoarthritis knees, plantar fasciitis and post-operative pain.

3) The overwhelmingly positive results of the recently published United Kingdom and Ireland Registry assessment of 5,000+ users

4) Surveys of users published this week in Pain Management

5) Sale of hundreds of thousands of devices.

http://www.prnewswire.com/news-releases/bioelectronics-files-fda-premarket-notification-for-actipatch-therapy-300125856.html